We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Staffline Group Plc | LSE:STAF | London | Ordinary Share | GB00B040L800 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.45 | -1.48% | 30.00 | 29.10 | 30.90 | 30.00 | 29.00 | 30.00 | 434,101 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Management Consulting Svcs | 938.2M | -11M | -0.0664 | -4.37 | 48.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2021 08:47 | Jim ,, don’t look ..... | gripfit | |
22/3/2021 08:22 | Think I would be banking them profits in tremor now John | gripfit | |
22/3/2021 08:16 | Big news AstraZeneca’s US clinical trial of its Covid-19 vaccine developed with Oxford university has shown 79 per cent efficacy at preventing symptomatic disease and 100 per cent efficacy against severe or critical disease and hospitalisation. A fifth of the participants in the trial were over the age of 65 and the jab showed 80 per cent efficacy in these older participants, the long-awaited results showed on Monday. The AstraZeneca vaccine is currently embroiled in a safety row in Europe, with some countries pausing its rollout after registering a series of rare side events involving a specific type of blood clot. The European regulator, the European Medicines Agency, has said throughout the safety crisis that the vaccine’s benefits far outweigh its risks, but some countries have opted to halt the rollout, pending more data. Crucially, the US trial found the vaccine was well tolerated, AstraZeneca said, and the independent data safety monitoring board identified no safety concerns related to the vaccine. | john09 | |
22/3/2021 08:11 | The rich get richer lol | gripfit | |
22/3/2021 08:09 | Trmr up 72p or as i prefer to call it 36 grand ;p | john09 | |
22/3/2021 08:08 | Europe looking dodgy mind because 1. They dont have enough vaccine and 2. They played politics with the. Vaccines they did have | john09 | |
22/3/2021 08:08 | Tremor trading ahead . Yep nice start 8% out of the blocks Expecting a good day for many stocks today US have trialled Astra Zeneca. 79% effective. Blood clots no issue | john09 | |
22/3/2021 08:07 | Down this goes shorts are us 🤣💦 | qsmeily456 | |
22/3/2021 08:06 | John ,, I bet your Tremor ing? | gripfit | |
22/3/2021 07:48 | No it was my erection | john09 | |
22/3/2021 07:47 | Well spotted, was it the light that gave it away ;) | gbh2 | |
21/3/2021 15:15 | Smartelly ,,, lol ... posting on Amigo ,,, 😂😂 | gripfit | |
20/3/2021 12:22 | It’s one of his holdings , that’s all | gripfit | |
19/3/2021 23:54 | I had an interesting couple of days at XLM Closed at 53p Wednesday. 12 month high Placing at 40p announced Thursday morning closed at 46p in sympathy. Normal. Expected Today closed at 51p almost like the discounted placing never happened . 14 m shares traded They liked the reason for the placing clearly ! | john09 | |
19/3/2021 23:44 | This is going to rocket | kirk 6 | |
19/3/2021 23:30 | Get ready Jimbo. Rocket ride soon Strap in | gutterhead | |
19/3/2021 23:29 | Grip, I’m desperate for you to see a profit as that means I’ll be able to buy a Dacia duster. | gutterhead | |
19/3/2021 23:20 | I didnt like to say But i was thinking of you lol | john09 | |
19/3/2021 23:12 | Yeh ,, like me .... | gripfit | |
19/3/2021 21:29 | Jim why do we assume todays sales were profit takers? They could have bought at £1.50 2 years ago | john09 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions